Search Within

Andrew D Seidman

  1. "Behavioral Sciences Service"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (13)
  3. Conference Paper (3)
Groups
  1. Behavioral Sciences Service (40)
  2. Breast Medicine Service (40)
  3. Department of Medicine (40)
  4. Psychiatry and Behavioral Sciences, Department of (40)
  5. Solid Tumor Oncology Division (40)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (38)

More Groups

People
  1. Clifford Hudis (38)
  2. Larry Norton (38)
  3. Teresa Gilewski (38)
  4. Violante Currie (24)
  5. Nancy Sklarin (22)
  6. Mary Ellen Moynahan (18)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2017 (1)
  4. 2014 (1)
  5. 2013 (1)
  6. 2011 (2)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Breast Cancer Research and Treatment (7)
  3. Clinical Cancer Research (4)
  4. Cancer Research (3)
  5. Seminars in Oncology (3)
  6. Clinical Breast Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Springer (9)
  3. American Association for Cancer Research (8)
  4. Elsevier Inc. (6)
  5. Oxford University Press (2)
  6. Informa Healthcare (1)

More Publishers

Results (40)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • "A tool, not a crutch": Patient perspectives about IBM Watson for Oncology trained by Memorial Sloan Kettering
    Journal Article

    Hamilton, J. G.; Genoff Garzon, M.; Westerman, J. S.; Shuk, E.; Hay, J. L.; Walters, C.; Elkin, E.; Bertelsen, C.; Cho, J.; Daly, B.; more...
    Journal of Oncology Practice (2019)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel and dasatinib in metastatic breast cancer
    Journal Article

    Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • "A tool, not a crutch': Patients with breast cancers' perceptions of the IBM Watson for Oncology clinical decision support system
    Meeting Abstract

    Hamilton, J. G.; Shuk, E.; Westerman, J. S.; Genoff, M. C.; Werk, R. S.; Pocus, V.; Hay, J. L.; Walters, C.; Elkin, E.; Gucalp, A.; more...
    Annals of Behavioral Medicine (2017)

    Fulltext@MSK | Save
  • A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Shah, P. D.; Charen, A. S.; Bromberg, J.; Comen, E. A.; D'Andrea, G.; Dang, C. T.; Gilewski, T.; Gucalp, A.; Lake, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Morris, P. G.; Lake, D. E.; D'Andrea, G. M.; Dickler, M. N.; Gilewski, T. A.; Dang, C. T.; McArthur, H. L.; Bromberg, J. F.; Goldfarb, S. B.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
    Journal Article

    Fornier, M. N.; Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; Modi, S.; Seidman, A. D.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • A feasibility study of bevacizumab plus dose-dense doxorubicin- cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer
    Journal Article

    Mcarthur, H. L.; Rugo, H.; Nulsen, B.; Hawks, L.; Grothusen, J.; Melisko, M.; Moasser, M.; Paulson, M.; Traina, T.; Patil, S.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • A phase I-II trial of dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Meeting Abstract

    Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Lake, D.; Bromberg, J.; Dang, C.; Dickler, M.; Modi, S.; Seidman, A. D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer
    Journal Article

    Drullinsky, P.; Sugarman, S. M.; Fornier, M. N.; D'Andrea, G.; Gilewski, T.; Lake, D.; Traina, T.; Wasserheit-Lieblich, C.; Sklarin, N.; Atieh-Graham, D.; more...
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save